PTS, Inc. Announces New Department for Enhanced Customer Service and Support

PTS, Inc. Announces New Department for Enhanced Customer Service and Support

Indianapolis, IN – July 6, 2012 – Polymer Technology Systems, Inc. (PTS, Inc.), the manufacturer of the CardioChek family of products, today announced the formation of a new department that will focus on customer service, technical support, customer training, internal product surveillance, complaint investigations, and the management of field evaluations and data. Known as the Regulatory and Clinical Affairs department, the group will also oversee proficiency testing and CRMLN certification.

The initiative to enhance customer service and support gained momentum when Elsa Chi Abruzzo joined PTS, Inc. on April 16, 2012 as Vice President of Regulatory and Clinical Affairs. Before coming to PTS, Inc., she was President and CEO of Abruzzo Regulatory Affairs Consulting (ARAC) in Cincinnati, Ohio. Her company was engaged in strategic regulatory, clinical, and quality consulting for the medical device, biologic, and pharmaceutical industry. Abruzzo has a successful track record spanning 23+ years with innovative medical devices and disruptive biotechnologies; has designed, developed and managed domestic and international clinical trials; and has implemented global regulatory strategies resulting in commercialization of products in the USA and worldwide.

Leading the Clinical Affairs group at PTS, Inc. will be Michelle Evans as Director of Clinical Affairs, with Bob Murphy managing the Midwest to East Coast region and Chris Campbell managing the Midwest to West Coast region. Ryan Jesswein, who is based in Indianapolis, will assist Evans with complaint investigations, technical support calls, customer training, internal product surveillance, and field evaluations, as well as domestic and international data management. The PTS, Inc. Customer Service department will also report to Evans.

“The establishment of a Clinical Affairs department consolidates our resources and highlights our commitment for customer service and support,” said Evans. “We want to make it easier for our customers to move from the point of sale to full utilization of all we have to offer, from training and field evaluations to tech support, and our Clinical Affairs department is designed to do just that.”

Jack Rogers, based in Indianapolis, has joined the company as Director of Regulatory Affairs, also reporting to Elsa Abruzzo.

Robert Huffstodt, President and CEO of PTS, Inc., said, “It’s great to have Elsa Abruzzo on board. She understands the importance of reliably and consistently providing our customers with exceptional products and services. Putting this Clinical Affairs team in place greatly enhances our ability to meet our customers’ needs, as our sales are growing quite dramatically. Jack Rogers rounds out the team nicely, and brings yet another dimension and skill set to our global business model.”

About Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 100 countries around the world. The company has sales offices in Africa, Australia, Europe, Latin America, the Middle East, and the Pacific Rim. PTS, Inc. products include the CardioChek® PA point-of-care instrument and the CardioChek® cholesterol analyzer that are marketed to the professional diagnostics industry and consumer screening market. The company offers lipid panel, LDL cholesterol, glucose, ketone, and other combination test strips for professional use with the CardioChek PA point-of-care instrument and the CardioChek Health Risk Assessment (HRA) software. For more information, visit www.cardiochek.com.

PTS, Inc. Signs Agreement to Provide Point-of-Care Lipid Testing to Life Line Screening

PTS, Inc. Signs Agreement to Provide Point-of-Care Lipid Testing to Life Line Screening

Indianapolis, IN – September 6, 2012 – Polymer Technology Systems, Inc. (PTS), the U.S.- based manufacturer of the CardioChek family of point-of-care diagnostic products, has announced the signing of a multiyear agreement to supply the CardioChek PA test system to Life Line Screening, a leading global provider of community-based preventive health screenings.

The CardioChek test system provides on-site lipid panel screening, which includes total cholesterol, HDL cholesterol, triglycerides, and LDL (calculated), as well as glucose, and delivers the results in less than two minutes.

According to Life Line Screening’s Laboratory Medical Director, Benjamin Gerson, MD, “PTS is an ideal partner for us. Life Line Screening is certified under the CLIA federal mandate with a Certificate of Compliance, and as such, our focus is on quality. We have 60 community-based teams throughout the U.S., conducting approximately 15,000 health screening events a year. The CardioChek system does not require a venous draw, allowing us to deliver fast results so our teams can provide clients with immediate feedback.”

Robert Huffstodt, President and CEO of PTS, Inc., is equally excited about the partnership. “Life Line Screening is a cutting-edge screening provider in the U.S. and abroad, and we are proud to have them implement our system around the world. They understand the role of preventive screening and have created a model that can deliver services on a global scale. This is very impressive and makes them a unique partner.” The ability to use this system globally is an important component of this partnership. “CardioChek is in over 120 countries, by far the most in the business,” said Kevin Luckow, Global Manager with Life Line Screening. “We are expanding our operations around the world, and they have the knowledge and experience in the intricacies of global business we need to grow.”

Life Line Screening intends to deploy the CardioChek test system immediately. “PTS has the products, operational efficiencies, training, and distribution in place that we were looking for,” continued Luckow. “Their system is accurate and easy to use. It doesn’t require refrigeration and is battery-operated, which are important operational benefits for our teams. We look forward to a long and mutually beneficial partnership.”

The CardioChek test system, FDA-cleared for marketing in the U.S., in accordance with pre-market notification requirements set forth by the FDA, are CE-marked for marketing in the European Union and are licensed or registered as required for marketing globally.

About Life Line Screening
Life Line Screening was established in 1993, and has since become the nation’s leading provider of preventive health screenings. Highly trained clinical teams are on staff across the nation to bring affordable screenings to convenient, neighborhood locations. These non-invasive, painless tests help people identify their risk for stroke, vascular diseases or osteoporosis early enough that they and their physicians can begin preventive procedures. Visit the website at www.lifelinescreening.com or call 1-800-697-9177.

About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world. The company has sales offices in Africa, Australia, Europe, Latin America, the Middle East and the Pacific Rim. PTS, Inc. products include the CardioChek® PA point-of-care instrument and the CardioChek® cholesterol analyzer that are marketed to the professional diagnostics industry and consumer screening market. The company offers tests for a Lipid Panel, LDL  Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek PA point-of-care instrument and the CardioChek Health Risk Assessment (HRA) software. For more information, visit www.cardiochek.com

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:
Kathleen Sutton
Director, US Marketing
Polymer Technology Systems, Inc.
Indianapolis, IN
317-870-5610

Life Line LIT# 001560

CardioChek Test System Accepted by HEART UK for Use in Nationwide Program​

CardioChek Test System Accepted by HEART UK for Use in Nationwide Program

Indianapolis, IN – September 20, 2012 – Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, announced today that HEART UK has accepted CardioChek as a point-of-care system for lipid testing in a nationwide health screening program. HEART UK, the United Kingdom’s (cholesterol) charity, works with the public and healthcare professionals to promote healthier lifestyles. HEART UK’s acceptance of CardioChek as a screening tool is a significant milestone, as PTS continues to expand its presence in global markets.

The CardioChek test system provides on-site lipid panel screening tests and delivers readings for total cholesterol, HDL cholesterol, triglycerides, LDL (calculated), and glucose in less than two minutes. CardioChek is represented in the UK by BHR Pharmaceuticals Ltd., a specialty distributor of point-of-care medical diagnostics.

Andrew Greaves, Sales Director for BHR, said he is delighted that HEART UK has approved CardioChek as a screening tool in the national “Health-Check” program, and he is confident that HEART UK’s acknowledgment will generate great interest within primary care organizations. Greaves continued, “As the Department of Health (UK) positions for greater awareness of the ‘Health-Check’ program, the drive to reduce the incidence of heart disease, and the need for reliable lipid testing in primary care, grows.”

Robert Huffstodt, President and CEO of PTS, Inc. said, “We are honored by this important acknowledgement by HEART UK. Their organization is very much respected for the work they do in cholesterol awareness and testing, and HEART UK’s recognition of the CardioChek system as a useful point-of-care screening tool is significant to our organization. With HEART UK’s dedication to healthcare and our proficiency in providing fast, reliable test results, I am confident our partnership will effectively detect and help to moderate the risk factors for heart disease in the United Kingdom.”

About HEART UK
HEART UK is registered as a charity with the Charity Commission (registered charity number 1003904) and as a company limited by guarantee with the Registrar of Companies (registered company number 02631049). HEART UK is an acronym, standing for Hyperlipidemia, Education, Atherosclerosis, and Research Trust UK. Visit the website at www.heartuk.org.uk.

About BHR Pharmaceuticals, LTD
BHR Pharmaceuticals Limited specializes in point-of-care (POC) medical diagnostics in six major fields; allergy, cardiovascular, diabetes, female health, gastro-intestinal and hematology. BHR works with the leading diagnostic manufacturers of the world to bring quality products to the UK market. The products and services offered by BHR have proven to be of great value to healthcare teams. With active support from BHR, PCT’s, GP’s and pharmacies achieve service framework objectives in a meaningful, timely and cost-effective manner. Visit the website at www.bhr.co.uk.

About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim.

PTS, Inc. products include the CardioChek® PA point-of-care device and the CardioChek Health Risk Assessment (HRA) software, that are marketed to the professional diagnostics industry and the consumer screening market. The company offers tests for a Lipid Panel, LDL Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek point-of-care device. Visit the website at www.cardiochek.com.

For further information, please contact:
Kathleen Sutton
Director of Marketing
Polymer Technology Systems, Inc.
Indianapolis, IN
317-870-5610

All trademarks used or mentioned in this release are protected by law.

HEART UK LIT 001564 Rev. 0 9-12

PTS, Inc. Signs Agreement with Fisher HealthCare to Distribute CardioChek® Products

PTS, Inc. Signs Agreement with Fisher HealthCare to Distribute CardioChek® Products

Indianapolis, IN – October 25, 2012 – Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of CardioChek point-of-care diagnostic products, has announced the signing of a multiyear distribution agreement with Fisher HealthCare (Fisher). Fisher HealthCare is part of Thermo Fisher Scientific Inc., an international company that serves customers within the pharmaceutical and biotech industries.

Per this agreement, Fisher will have access to the CardioChek test system, which provides on-site ketone, glucose, and lipid panel readings in less than two minutes.

The CardioChek system does not require a venous draw or refrigeration, allowing healthcare providers to offer fast results to patients in a variety of settings.

This new agreement with PTS, Inc. fits with Fisher’s strategic plan to expand its presence within the Point-of-Care Testing (POCT) market.

According to Joyce Trost, Director of National Distribution for PTS, Inc., the agreement grew out of discussions with Fisher in response to an unmet need within the Point of Care Testing market. “Throughout our discussions, it became increasingly apparent that Fisher HealthCare’s expansion into the POCT market and PTS, Inc.’s targeted strategy were in full alignment, thereby significantly enhancing PTS, Inc.’s access to the clinical diagnostic market segments of the IDN and Health System in general.”

Robert Huffstodt, President and CEO of PTS, Inc. said, “We have invested our resources in the design and manufacturing of products to serve the clinical diagnostic market, and our agreement with Fisher HealthCare not only validates our investment, it also solidifies our presence in this market. PTS is proud to be positioned as a global partner for improving health and enhancing wellness, and we are very pleased to be partnering with Fisher HealthCare to improve patient diagnostics.”

The CardioChek test system is FDA-cleared for marketing in the U.S., in accordance with pre-market notification requirements as set forth by the FDA, as well as CLIA-waived. It is also CE-marked for marketing in the European Union.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Their mission is to enable their customers to make the world healthier, cleaner, and safer. With revenues of $12 billion, Fisher has approximately 39,000 employees and serves pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies, as well as in environmental and process control industries. Their products and services help their customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com for more information.

About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world with sales offices in Europe, Latin America, and the Pacific Rim.

PTS, Inc. products include the CardioChek® PA point-of-care device and the CardioChek Health Risk Assessment (HRA) software, that are marketed to the professional diagnostics industry and the healthcare screening market. The company offers tests for a Lipid Panel, LDL Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek point-of-care device. Visit the website at www.cardiochek.com.

Media contact:
Kathleen Sutton
Director of U.S. Product Management
Polymer Technology Systems, Inc.
Indianapolis, IN
317-870-5610

All trademarks used or mentioned in this release are protected by law.

LIT001566 Rev. 0 11/12

Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients

Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group’s Hospital Clients

On-Site Lipid Results Simplified and Expedited with Wireless Technology

(INDIANAPOLIS, IN – June 10, 2013) — Polymer Technology Systems, Inc. (PTS) announced a partnership with Aegis Health Group  to integrate the CardioChek® PA system into Aegis workforce wellness programs administered by health systems across the country. The CardioChek PA lipid testing system, manufactured by PTS and distributed through Hanson Medical Systems, offers immediate, on-site results for total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and glucose.

The CardioChek PA test system will be available to health systems using Aegis’ employer relationship management program, through which hospitals work with local employers to improve population health. Using CardioChek allows hospitals to instantaneously collect and record biometric data at health fairs and on site at employer locations. Screening results are transmitted in less than two minutes to Aegis’ health management application, OneCommunity. As a result, both patients and healthcare providers have immediate feedback about a test used to identify critical health risks on the spot.

“The CardioChek PA analyzer is an excellent choice because it delivers quick, accurate results and provides a seamless interface that empowers patients with insight about important health parameters,” said Pearson Talbert, president and CEO of Aegis Health Group. “Point-of-care lipid testing is the perfect complement to hospitals’ workforce health partnerships with local employers because it allows clinicians to spend less time screening and more time consulting with patients, which increases efficiency for health systems and reduces costs for employers.”

Without the CardioChek PA analyzer, when hospitals and wellness companies conduct on-site biometric screenings for employer groups, blood samples must be processed through a laboratory and results manually added to patients’ health records which is a process that can take up to two weeks. This new partnership between PTS and Aegis allows test results to be automatically added to a participant’s health risk profile within OneCommunity, Aegis’ population health portal, in a matter of minutes.

Hanson Medical Systems, a trusted partner of PTS with a broad distribution network, has been selected to distribute CardioChek PA systems to Aegis’ client locations nationwide. “We are very excited to be working with two national leaders – Aegis Health Group and Hanson Medical Systems – on this important initiative,” said Robert Huffstodt, President and CEO of PTS. “With Aegis’ dedication to improving health and PTS’s proficiency in providing fast, reliable test results, our partnership will help detect and address health risk factors for people throughout the U.S.”

About Polymer Technology Systems, Inc. (PTS)
Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Ind., PTS designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS products include the CardioChek PA point-of-care instrument, which is marketed to the professional diagnostics industry, and the CardioChek cholesterol analyzer for consumer use. The company offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketone as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com.

About Aegis Health Group
Aegis Health Group has assisted hundreds of hospitals with proven-effective business development strategies for more than 20 years. Its strategic Population Health Management solutions enable hospitals to grow market share and revenue by identifying and intelligently managing the health risks of local consumers within the community they serve. Complementing this, Aegis’ data-driven Physician Relationship Management strategy creates strategic alignment between hospitals and their medical staffs to drive service-line growth, enhance patient care and quality, and provide timely issue resolution. Further information about Aegis is available at www.AegisGroup.com or on their blog at www.aegishi4.com.

About Hanson Medical Systems, Inc.
Since 1984, with corporate offices in Orlando, Florida, Hanson Medical Systems, Inc. has been a specialty consultant and medical products distributor with a specific focus on CLIA-waived, point-of-care diagnostics for the wellness and health promotion markets. Hanson Medical Systems serves hospitals, health screeners, government agencies, and other healthcare providers within the United States with their community and corporate wellness screening initiatives. Further information about Hanson Medical Systems, Inc. can be found at www.hansonmed.com.

LIT 001578 Rev. 0 06/13